BEIJING, Aug. 8, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce the appointment of Cheng Chi Kin (Patrick Cheng) as Chief Financial Officer and to the Board of Directors of the Company, effective immediately. With a distinguished career spanning over three decades in corporate management, investment, and financial control, Patrick Cheng will drive Origin Agritech's financial strategy and operatio ...

Core Viewpoint - Origin Agritech Ltd. has appointed Mr. Li Yang as Chief Operating Officer and a member of the Board of Directors, effective immediately, to enhance its operational strategy and execution [1][3]. Company Overview - Origin Agritech Limited, founded in 1997 and headquartered in Beijing, is a leading Chinese agricultural technology company known for its innovations in crop seed biotechnologies [4]. - The company has developed a robust biotechnology seed pipeline, including phytase corn, which was the first transgenic corn to receive a Bio-Safety Certificate from China's Ministry of Agriculture [4]. Leadership Appointment - Mr. Li Yang brings over 20 years of experience in investment activities and corporate management, having held directorships in several prominent companies listed on Hong Kong stock exchanges [2]. - His expertise includes corporate governance, strategic planning, mergers and acquisitions, and operational management, which will be crucial for Origin Agritech's market presence and technological expansion [2]. Executive Statements - Dr. Gengchen Han, Chairman and CEO of Origin Agritech, expressed confidence in Mr. Li Yang's leadership and operational expertise, anticipating significant contributions to the company's growth and success [3]. - Mr. Li Yang expressed enthusiasm about joining Origin Agritech and aims to enhance operational efficiency and strategic development [3]. Educational Background - Mr. Li Yang holds a Master's Degree in World Economics from the Chinese Academy of Social Sciences and an MBA from Shenzhen Economic and Management Institute, along with a diploma from Shenzhen University [3].

Core Insights - SEED Therapeutics has entered a strategic research collaboration with Eisai to develop novel molecular glue degraders targeting neurodegeneration and oncology [1][2] - The collaboration includes financial terms that allow SEED to receive up to $1.5 billion in payments and tiered royalties from Eisai [2] - SEED has initiated Series A-3 financing, raising $24 million in the first close, with a second close planned for Q4 2024 [3] Collaboration Details - SEED will lead preclinical discovery activities, while Eisai will have exclusive rights to develop and commercialize the resulting compounds [2] - This collaboration follows an ongoing partnership between SEED and Eli Lilly for the development of molecular glue degraders [2] Series A-3 Financing - The Series A-3 financing aims to accelerate SEED's clinical development in cancer and neurodegeneration, expanding its TPD platform and pipeline [3] - SEED plans to advance its oral RBM39 Degrader into Phase 1 testing in 2025 and its Tau degrader program for Alzheimer's into in vivo efficacy testing in 2025, with an IND submission in 2026 [3] Company Background - SEED Therapeutics focuses on developing molecular glues and targeted protein degradation therapies for previously undruggable targets, with a growing pipeline in neurodegeneration and oncology [6] - The company has collaborations with both Eisai and Eli Lilly, enhancing its capabilities in drug development for neurodegenerative diseases [5][6] Eisai's Role - Eisai is recognized for its commitment to human health care and aims to address unmet medical needs in neurology and oncology through innovative products [7] - The collaboration with SEED is seen as a unique opportunity to leverage molecular glue technology in both oncology and neurology [4]

BEIJING, July 23, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce its revenue projections for key product lines through the year 2029.GMO Corn Application to Approval TimelineRevenue Projections Revenue from hybrid seeds and other Revenue from NEC Revenue from GMO Total Revenue(￥'000) Total Revenue(US$'000) 2022  ￥52,580 - -  ￥52,580 $7,240 2023  ￥93,307 - -  ￥93,307 $12,848 2024 (Expected)  ￥ ...

Origin Agritech Limited (NASDAQ:SEED) Special Call July 11, 2024 8:00 AM ET Company Participants Matthew Abenante - Strategic Investor Relations Gengchen Han - Chairman and CEO Kate Lang - Director of Investor Relations Conference Call Participants Operator Thank you for standing by and welcome to the Origin Agritech Business Update Conference call. Please note that today's call is being recorded. It is now my pleasure to introduce Matthew Abenante of Strategic Investor Relations. Matthew Abenante Thank you ...

BEIJING, July 11, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, provided a business update from Dr. Gengchen Han, Chairman and CEO of Origin Agritech.Dear Shareholders,We are pleased to provide you with an update on our recent developments, including our progress in GMO commercialization, the performance of our commercial hybrids, and advancements in our gene editing business.GMO Commercialization DevelopmentsRecently ...

BEIJING, June 20, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, will host a conference call on Thursday, July 11, at 8:00 AM ET (8:00 PM Beijing Time) with the investment community. The presentation will be led by Dr. Gengchen Han, Chairman and CEO of Origin Agritech. Investors may submit written questions by July 1st via e-mail to: [email protected].     INVESTOR WEBCAST It is recommended that participants access the ...

BEIJING, June 12, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the publication of a groundbreaking research article in the prestigious scientific journal Nature, titled "Maize Smart Canopy Architecture Enhances Yield at High Densities." This study is the first to successfully achieve fixed-point improvement of leaf angle in maize inbred lines using maize induction line gene editing technology.The arti ...

BEIJING, May 15, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced its unaudited financial results for the six months ended March 31, 2024. The Company also provided updates on its key product developments and strategic initiatives. Financial Results Overview: Revenue Growth: Origin Agritech reported net revenues of RMB 92 million (US$13 million) for the first half of FY2024, marking a substantial increase ...

Exhibit 99.1 Origin Agritech Limited ("Origin" or the "Company"), an agriculture technology company in China, is filing its unaudited financial results for the first half of FY2024 ended March 31, 2024, prepared in accordance with United States generally accepted accounting principles. FINANCIAL RESULTS OVERVIEW The Company reported net revenue of RMB92.0 million (US$13.0 million) during the first half year of FY2024, compared to RMB66.1 million for the first half year of FY2023. Total operating expenses fo ...